Global Radiopharmaceuticals Market 2017-2021
- SKU ID : TNV-IRTNTR14246 10986422
- |
- Publishing Date: 09-Aug-2017
- |
- Region: Global
- |
- No. of pages: 83
About Radiopharmaceuticals
Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand for radiopharmaceuticals for both therapeutic and diagnostic segments. Some of the other major segments finding the huge application of radiopharmaceuticals are neurology, cardiology, and thyroid disorder treatment.
Technavio’s analysts forecast the global radiopharmaceuticals market to grow at a CAGR of 9.02% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global radiopharmaceuticals market for 2017-2021. To calculate the market size, the report considers the sales of radiopharmaceuticals.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Radiopharmaceuticals Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Bayer,
• Cardinal Health,
• GE Healthcare,
• Lantheus Medical Imaging
Other prominent vendors
• ABT Molecular Imaging
• Advanced Accelerator Applications
• Algeta
• Eczacibasi-Monrol Nuclear Products
• FUJIFILM Holdings
• Isologic Innovative Radiopharmaceuticals
• Nordion
• Piramal Imaging
• RadioMedix
• Triad Isotopes
Market driver
• Rising burden of the neurological disorders
• For a full, detailed list, view our report
Market challenge
• Shortage of radioisotopes
• For a full, detailed list, view our report
Market trend
• Partnerships for development of radiopharmaceuticals
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand for radiopharmaceuticals for both therapeutic and diagnostic segments. Some of the other major segments finding the huge application of radiopharmaceuticals are neurology, cardiology, and thyroid disorder treatment.
Technavio’s analysts forecast the global radiopharmaceuticals market to grow at a CAGR of 9.02% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global radiopharmaceuticals market for 2017-2021. To calculate the market size, the report considers the sales of radiopharmaceuticals.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Radiopharmaceuticals Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Bayer,
• Cardinal Health,
• GE Healthcare,
• Lantheus Medical Imaging
Other prominent vendors
• ABT Molecular Imaging
• Advanced Accelerator Applications
• Algeta
• Eczacibasi-Monrol Nuclear Products
• FUJIFILM Holdings
• Isologic Innovative Radiopharmaceuticals
• Nordion
• Piramal Imaging
• RadioMedix
• Triad Isotopes
Market driver
• Rising burden of the neurological disorders
• For a full, detailed list, view our report
Market challenge
• Shortage of radioisotopes
• For a full, detailed list, view our report
Market trend
• Partnerships for development of radiopharmaceuticals
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
